pcDNA5 TO哺乳动物表达载体说明
pEF1α-IRES-DsRed-Express2哺乳动物表达载体说明
![pEF1α-IRES-DsRed-Express2哺乳动物表达载体说明](https://img.taocdn.com/s3/m/1c2b512b5727a5e9856a617e.png)
GTTAGGCCAG TCTTGGTTCA TCGTGACGCT CGGTACCGCG AGCCGCTTGG TCTTTTGGCA GGTCTTTCCC CCTCTGGAAG CCCCCACCTG AAGGCGGCAC CTCTCCTCAA GGATCTGATC CGTCTAGGCC GGCCACAACC CATGGAGGGC CTACGAGGGC CTGGGACATC CGACATCCCC GAACTTCGAG CTTCATCTAC GAAGAAGACT GAAGGGCGAG CAAGTCAATC CAAGCTGGAC CGAGGCCCGC CCACATTTGT AACATAAAAT AATAAAGCAA GTGGTTTGTC TTAAAATTCG GGCAAAATCC TGGAACAAGA TATCAGGGCG TGCCGTAAAG AAGCCGGCGA CTGGCAAGTG CTACAGGGCG TTTTTCTAAA CAATAATATT AGTTAGGGTG TCAATTAGTC AAAGCATGCA CCCTAACTCC ATGCAGAGGC
GGAGACTGAA TGAGTTTGGA ATTTCAGGTG CTGCAGTCGA TACTGGCCGA CATATTGCCG CATTCCTAGG GGAAGCAGTT GCAGCGGAAC TACACCTGCA AGTCAAATGG CCATTGTATG GTTAAAAAAA ATGATAATAT TCAAGGTGCA AGGGCAAGCC TGCCCTTCGC AGCACCCCGC AGCGCGTGAT AGGACGGCAC CCGTAATGCA ACGGCGTGCT TGGTGGAGTT ACGTGGACTC ACGAGCGCGC ATCAGCCATA CTGAACCTGA AATGGTTACA CATTCTAGTT TAATATTTTG GGCCGAAATC TGTTCCAGTT AAAAACCGTC GGGGTCGAGG TTGACGGGGA CGCTAGGGCG TAATGCGCCG TATTTGTTTA ATAAATGCTT AATGTGTGTC AGCATGCATC AGAAGTATGC CCCATCCCGC TTTTTTATTT
pcDNA3.1-EGFP
![pcDNA3.1-EGFP](https://img.taocdn.com/s3/m/2d9f2b207375a417866f8fb2.png)
Ampicillin (氨苄青霉素)
筛选标记:
Neomycin / G418
pcDNA3.1-EGFP质粒图谱
载体特点
1.此载体骨架为Invitrogen公司的pCDNA3.1(+)。
2.EGFP插入位点为EcoRI、NotI。
3.此载体已验证:将此载体转染至293细胞、Hela细胞、CHO细胞等多株细胞,24小时后观察荧光,可见多且亮的绿色荧光。
2043-2471:f1 ori
2476-2819:SV40 promoter
2881-3675:Neo(R)
3849-3979:SV40 polyA
4362-5032:pUC ori(反向)
5177-6037:Amp(R)(反向)
6038-6136:bla promoter(反向)
pcDNA3.1-EGFP载体
出品公司:
Invitrogen
质粒类型:
哺乳动物表达载体启动子:Fra bibliotekCMV
表达水平:
高
克隆方法:
多克隆位点,限制性内切酶
载体大小:
6173 bp
5'测序引物:
CMV-f:5’-CGCAAATGGGCGGTAGGCGTG-3’
3'测序引物:
BGH-R:5’-TAGAAGGCACAGTCGAGG-3’
4.此载体可作为pCDNA3.1(+)系列的NC对照载体使用,亦可用来构建目的基因-EGFP基因融合形式的基因过表达载体。
5.此载体带有Neo抗性基因,可在真核细胞中用G418进行筛选。
Location of features
232-819:CMV promoter
microRNA过表达载体构建技术的实验研究
![microRNA过表达载体构建技术的实验研究](https://img.taocdn.com/s3/m/f6dd6372793e0912a21614791711cc7930b7785a.png)
microRNA过表达载体构建技术的实验研究姜彬【摘要】目的:构建microRNA的表达载体,再转染生物体细胞观察该microRNA的转录或表达情况,以获知它的作用机理及对生物体的影响。
方法:以microRNA-21(简化为miR-21)为例说明构建表达载体的方法。
根据microRNA的成熟序列以及附近约200多碱基共约470个碱基序列,设计PCR 引物,PCR扩增,PCR产物和pcDNA3.1(+)质粒双酶切后,用T4连接酶进行连接反应,并转化入感受态细胞,筛选后对重组质粒进行双酶切、琼脂糖凝胶电泳鉴定及测序分析,并将其转染 Hela细胞,经 RT-PCR实验检测其表达情况。
结果:pcDNA3.1(+)/miR-21过表达载体转染细胞后使得miR-21在细胞中过表达。
结论:成功构建了miR-21的真核表达载体,为进一步研究miR-21功能及作用机制奠定实验基础。
%This article introduces how to construct miRNA-21 overexpression vector and transfect it into cell ( Hela). Then the level of expression of miR-21 was observed. The miR-21 precursor is amplified by PCR method ,then the recombinant vector pcDNA3.1 (+ ) and miR-21 are constructed. After screening and identifying the recombinant ,it is transfected into cancer cells (Hela).The miR-21 expressing level is detected by RT-PCR.The result shows that the level of the miR-21 expression increases significantly in the cells that are transfected the recombinant. The miR-21 overexpression vector is successfully constructed ,and a foundation for studying the function of miR-21 is established .【期刊名称】《实验技术与管理》【年(卷),期】2014(000)001【总页数】5页(P41-44,48)【关键词】微小RNA;miR-21;pcDNA3.1(+)【作者】姜彬【作者单位】北京大学医学部生化系,北京 100191【正文语种】中文【中图分类】Q5221 microRNA概述1993年,Lee等[1]在线虫中发现了小分子单链非编码RNA,其长度只有22nt,当时命名为1in-4。
pAD-SV40T使用说明
![pAD-SV40T使用说明](https://img.taocdn.com/s3/m/17435346f01dc281e53af0b7.png)
pAD-SV40T编号载体名称北京华越洋VECT76070pAD-SV40TpAD-SV40T载体图谱:pAD-SV40T载体简介:The pAD-SV40T control plasmid expresses a hybrid protein which contains the NF-κB transcription activation domain fused to amino acids84–708of the SV40large T-antigen.5pAD-SV40T载体相关的哺乳动物表达载体:SuperCos I pDsRed2-Bid pNFκB-MetLuc2-ReporterpYr-adshuttle-3pAcGFP1-N1pEF1α-IRES-DsRed-Express2pVitro2-neo-mcs pSecTag2A pCMV-DsRed-Express2pUB6/V5-His/LacZ pGL4.27pcDNA3.1/NT-GFP-TOPOpUB6/V5-His C pGL4.26pEF1α-IRES-ZsGreen1pUB6/V5-His B pACT pCMV-Tag2ApUB6/V5-His A pBIND-Id Control pCMV-Tag5BpTracer-CMV2pTRE2pAcGFP1-C In-Fusion ReadypSV-β-Galactosidase pRevTRE p3XFLAG-CMV-14pSI pTK-hyg p3XFLAG-CMV-8pSG5pTRE3G-Luc pFLAG-CMV-2pSFV1pSwitch pcDNA3.3-TOPOpSecTag2/Hygro A pcDNA4/His C pcDNA6.2/cLumio-DESTpSecTag B c-Flag pcDNA3pCMV-tdTomatopRluc-N2pcDNA4/TO/Myc-His A pAcGFP1-MitopPICZalpha D pcDNA6/myc-His B pAcGFP1-N In-Fusion Ready pORF-lacZ pcDNA6/V5-His B pDsRed-Monomer-N In-Fusion Ready pORF-HSV1tk pcDNA6.2/nTC-Tag-DEST pcDNA4/TO/Myc-His BpOG44pOptiVEC-TOPO pIRES2-EGFPpNTAP-B pcDNA5/FRT pcDNA3.1/His CpMEP4pGL4.30pcDNA3.1/CT-GFP-TOPOpLVX-ZsGreen-miRNA-Puro pGL4.19pEF1α-IRES-AcGFP1pLVX-IRES-Puro-3xFlag pACT-MyoD pcDNA3.2/V5/GW/D-TOPO pLPCX pCMV-BD pcDNA4/TO/Myc-His/LacZ pLEGFP-N1pCMV-Tet3G pcDNA4/HisMax-TOPOpKH3pTet on advanced p3XFLAG-CMV-13pIRES-puro2pTRE-Tight p3xFLAG-CMV-10phRL-TK pIND pFLAG-CMV-3pG5lac pGene/V5-His B pcDNA4/TO/Myc-His CpFR-luc pOPRSVI pcDNA6.2/C-YFP-DESTpEF6/myc-His C pcDNA4/HisMax A pcDNA6.2/cTC-Tag-DESTpEF4/V5-His A pIRESpuro3pcDNA6.2/nGeneBLAzer-DESTpEF1/myc-His lacZ pIRESneo3pCRE-MetLuc2-ReporterpEF1/myc-His C pIRESneo2pEF1α-DsRed-Express2pEF1/myc-His B pcDNA4/myc-His A pDsRed-Express-C1pEF1/myc-His A pCMV-PKA pEF1α-DsRed-Monomer-N1 pECFP-Mito pAcGFP1-N3pDD-AmCyan1ReporterpECFP-ER pcDNA5/FRT/TO pCRE-DD-AmCyan1pDP8rs pBApo-CMV-Pur pIRES2-DsRed-Express2pDP5rs pBApo-EF1α-pur pDsRed-Express-N1pDP4rs ptdTomato-N1pcDNA6.2/nLumio-DESTpDP3rs pAcGFP1-Golgi pcDNA6/myc-His ApDP2rs pAcGFP1-p53pcDNA6/V5-His ApDP1rs pAcGFP1-Actin pcDNA5/FRT/TO-TOPOpCMV-Myc-C pBI-CMV2pcDNA6.2/V5/GW/D-TOPOpCMV-HA-N pEF1α-tdTomato pcDNA6.2/cGeneBLAzer-DEST pCMV-HA-C pEF1α-tdTomato pcDNA6.2/nGeneBLAzer-GW/D-TOPO pCMV6-XL4pEBVHis A pcDNA5/TOpCMV6-AC-GFP pGL4.10pBApo-CMV-neopCMV5pGL4.29pDsRed-MonomerpCI pGL4.13pIRESpCGN pG5luciferase pIRES-hrGFP-1apcDNA6.2/EmGFP-Bsd/V5-DEST pCMV-AD pDsRed-Express2-N1pcDNA4/V5-His A pRevTet-Off pCMV-Tag3BpcDNA3-mRFP pTet-Off pCRE-hrGFPpcDNA3-CFP pTRE2-hygro pDsRED2-MitopcDNA3.1(+)/myc-His C pVgRxR pAcGFP1-FpcDNA3.1(+)/myc-His A pOPI3CAT pAcGFP1-C1pcDNA3.1(+)/CAT pBK-RSV pAsRed2-C1pcDNA3.1(-)/myc-His C pIRES2-DsRed2pAsRed2-N1pcDNA3.1/Zeo(+)pCMV-Myc pAcGFP1-LampcDNA3.1/Zeo(-)pCMV-Tag2C pAcGFP1-CpcDNA3.1/V5-His C pCMV-Tag5A pSEAP2-BasicpcDNA3.1/Hygro(+)pCMV-Tag3C pBI-CMV3pcDNA3.1/Hygro(-)p3XFLAG-CMV-7pNFkB-DD-tdTomatopcDNA3.1/GS p3XFLAG-CMV-9pcDNA3.1/His ApBS185CMV-Cre pFLAG-CMV-4pEBVHis BpBIND-GFP pBI-CMV4pGL4.75pBiFC-VN155(I152L)pcDNA4/His A pGL4.20pBiFC-CC155pcDNA4/myc-His B pCMV-SPORT6pBiFC-CrN173pcDNA4/HisMax C pCMV-SPORT6pBiFC-bJunVN155(I152L)pCMV-Tag4A pBINDpBD-p53pcDNA6/myc-His C pBD-NF-κBpBD-NF-kB pCMV-Tag2B pRevTet-OnpBC1pGRN145pTet-OnpAD-TRAF pCMV-MEK1pTRE3GpAD-SV40T pCMV-Tag3A pcDNA4/TOpAAV-ZsGreen-miRNA pCMVLacI pcDNA4/His B pAAV-tTS-shRNA pBI-CMV1pcDNA4/HisMax B pIREShyg3pEF1α-AcGFP1-N1pcDNA4/myc-His C pcDNA6/TR pCMV-LacZ pcDNA3.1/His B pDsRed-Express2-C1pCMV-Tag4B pcDNA6/V5-His C pBI-CMV5pCMV-Tag5C pCHO1.0 pAmCyan1-C1plRES2-ZsGreen1pGL3-Promoter pAcGFP1-Mem p3XFLAG-CMV-7.1pCMV-MEKK1 pAcGFP1-C3pFLAG-CMV-5a pFLAG-CMV2 pTT5pBudCE4.1pAcGFP1-C2 pSEAP2-Control pREP4ptdTomato-C1 pIRES2-AcGFP1pBApo-CMV pCRE-DD-tdTomato pAcGFP1-Hyg-C1。
pcDNA4 myc-His C哺乳动物表达载体说明
![pcDNA4 myc-His C哺乳动物表达载体说明](https://img.taocdn.com/s3/m/a18e2a0c10a6f524ccbf857c.png)
pcDNA4/myc-His C编号 载体名称北京华越洋生物VECT6123 pcDNA4/myc-‐His C pcDNA4/myc-‐His C载体基本信息载体名称: pcDNA4/myc-His C质粒类型: 哺乳动物表达载体;cDNA表达载体高拷贝/低拷贝: 高拷贝克隆方法: 多克隆位点,限制性内切酶启动子: CMV载体大小: 5071 bp5' 测序引物及序列: T7 Forward: 5’-TAATACGACTCACTATAGGG-3’ 3' 测序引物及序列: BGH Reverse: 5-TAGAAGGCACAGTCGAGG-3 载体标签: His Tag (C-端), c-Myc Epitope Tag(C-端)载体抗性: 氨苄青霉素筛选标记: Zeocin克隆菌株: TOP10F´, DH5a, JM109, TOP10宿主细胞(系): 常规细胞系,如293、Hela等备注: pcDNA4/myc-His C 载体是哺乳动物表达载体,适用于cDNA的表达与克隆;CMV启动子驱动目的基因的高水平表达;pcDNA4/myc-His A,B,C的区别仅在于多克隆位点处。
稳定性: 瞬表达或稳表达组成型/诱导型: 组成型病毒/非病毒: 非病毒pcDNA4/myc-‐His C载体质粒图谱和多克隆位点信息pcDNA4/myc-‐His C载体描述pcDNA4/myc-His A, B, and C are 5.1 kb vectors designed for overproduction of recombinant proteins in mammalian cell lines. Features of the vectors allow purification and detection of expressed proteins (see pages 11-12 for more information). High-level stable and transient expression can be carried out in most mammalian cells. The vectors contain the following elements:Human cytomegalovirus immediate-early (CMV) promoter for high-level expression in a wide range of mammalian cellsThree reading frames to facilitate in-frame cloning with a C-terminal peptide encoding the myc (c-myc) epitope and a polyhistidine (6xHis) metal-binding tagZeocin resistance gene for selection of stable cell lines (Mulsant et al., 1988) (see page 14 for more information).Episomal replication in cell lines that are latently infected with SV40 or that express the SV40 large T antigen (e.g., COS7).The control plasmid, pcDNA4/myc-His/lacZ is included for use as a positive control for transfection, expression, and detection in the cell line of choice.实验流程:Use the following outline to clone and express your gene of interest in pcDNA4/myc-His:1.Consult the multiple cloning sites described on pages 3-4 to determine which vector (A, B, or C) to use for cloning your gene in frame with the C-terminal myc epitope and the polyhistidine tag.2.Ligate your insert into the appropriate vector and transform into E. coli. Select transformants on 50 to 100 μg/mL ampicillin or 25 to 50g/mL Zeocin in Low Salt LB. For more information.3.Analyze your transformants for the presence of insert by restriction digestion.4.Select a transformant with the correct restriction pattern and use sequencing to confirm that your gene is cloned in-frame with the C-terminal peptide.5.Transfect your construct into the cell line of choice using your own method of transfection. Generate a stable cell line, if desired.6.Test for expression of your recombinant gene by western blot analysis or functional assay. For antibodies to the myc epitope or the C-terminal polyhistidine tag.7.To purify your recombinant protein, you may use metal-chelating resin such as ProBond. ProBond resin is available separatelypcDNA4/myc-‐His C载体序列ORIGIN1 GACGGATCGG GAGATCTCCC GATCCCCTAT GGTCGACTCT CAGTACAATC TGCTCTGATG61 CCGCATAGTT AAGCCAGTAT CTGCTCCCTG CTTGTGTGTT GGAGGTCGCT GAGTAGTGCG 121 CGAGCAAAAT TTAAGCTACA ACAAGGCAAG GCTTGACCGA CAATTGCATG AAGAATCTGC 181 TTAGGGTTAG GCGTTTTGCG CTGCTTCGCG ATGTACGGGC CAGATATACG CGTTGACATT 241 GATTATTGAC TAGTTATTAA TAGTAATCAA TTACGGGGTC ATTAGTTCAT AGCCCATATA 301 TGGAGTTCCG CGTTACATAA CTTACGGTAA ATGGCCCGCC TGGCTGACCG CCCAACGACC 361 CCCGCCCATT GACGTCAATA ATGACGTATG TTCCCATAGT AACGCCAATA GGGACTTTCC 421 ATTGACGTCA ATGGGTGGAC TATTTACGGT AAACTGCCCA CTTGGCAGTA CATCAAGTGT 481 ATCATATGCC AAGTACGCCC CCTATTGACG TCAATGACGG TAAATGGCCC GCCTGGCATT 541 ATGCCCAGTA CATGACCTTA TGGGACTTTC CTACTTGGCA GTACATCTAC GTATTAGTCA 601 TCGCTATTAC CATGGTGATG CGGTTTTGGC AGTACATCAA TGGGCGTGGA TAGCGGTTTG 661 ACTCACGGGG ATTTCCAAGT CTCCACCCCA TTGACGTCAA TGGGAGTTTG TTTTGGCACC 721 AAAATCAACG GGACTTTCCA AAATGTCGTA ACAACTCCGC CCCATTGACG CAAATGGGCG 781 GTAGGCGTGT ACGGTGGGAG GTCTATATAA GCAGAGCTCT CTGGCTAACT AGAGAACCCA 841 CTGCTTACTG GCTTATCGAA ATTAATACGA CTCACTATAG GGAGACCCAA GCTGGCTAGT 901 TAAGCTTGGT ACCGAGCTCG GATCCACTAG TCCAGTGTGG TGGAATTCTG CAGATATCCA 961 GCACAGTGGC GGCCGCTCGA GGTCACCCAT TCGAACAAAA ACTCATCTCA GAAGAGGATC 1021 TGAATATGCA TACCGGTCAT CATCACCATC ACCATTGAGT TTAAACCCGC TGATCAGCCT 1081 CGACTGTGCC TTCTAGTTGC CAGCCATCTG TTGTTTGCCC CTCCCCCGTG CCTTCCTTGA 1141 CCCTGGAAGG TGCCACTCCC ACTGTCCTTT CCTAATAAAA TGAGGAAATT GCATCGCATT 1201 GTCTGAGTAG GTGTCATTCT ATTCTGGGGG GTGGGGTGGG GCAGGACAGC AAGGGGGAGG 1261 ATTGGGAAGA CAATAGCAGG CATGCTGGGG ATGCGGTGGG CTCTATGGCT TCTGAGGCGG 1321 AAAGAACCAG CTGGGGCTCT AGGGGGTATC CCCACGCGCC CTGTAGCGGC GCATTAAGCG 1381 CGGCGGGTGT GGTGGTTACG CGCAGCGTGA CCGCTACACT TGCCAGCGCC CTAGCGCCCG 1441 CTCCTTTCGC TTTCTTCCCT TCCTTTCTCG CCACGTTCGC CGGCTTTCCC CGTCAAGCTC 1501 TAAATCGGGG CATCCCTTTA GGGTTCCGAT TTAGTGCTTT ACGGCACCTC GACCCCAAAA 1561 AACTTGATTA GGGTGATGGT TCACGTAGTG GGCCATCGCC CTGATAGACG GTTTTTCGCC 1621 CTTTGACGTT GGAGTCCACG TTCTTTAATA GTGGACTCTT GTTCCAAACT GGAACAACAC 1681 TCAACCCTAT CTCGGTCTAT TCTTTTGATT TATAAGGGAT TTTGGGGATT TCGGCCTATT 1741 GGTTAAAAAA TGAGCTGATT TAACAAAAAT TTAACGCGAA TTAATTCTGT GGAATGTGTG 1801 TCAGTTAGGG TGTGGAAAGT CCCCAGGCTC CCCAGGCAGG CAGAAGTATG CAAAGCATGC 1861 ATCTCAATTA GTCAGCAACC AGGTGTGGAA AGTCCCCAGG CTCCCCAGCA GGCAGAAGTA 1921 TGCAAAGCAT GCATCTCAAT TAGTCAGCAA CCATAGTCCC GCCCCTAACT CCGCCCATCC 1981 CGCCCCTAAC TCCGCCCAGT TCCGCCCATT CTCCGCCCCA TGGCTGACTA ATTTTTTTTA 2041 TTTATGCAGA GGCCGAGGCC GCCTCTGCCT CTGAGCTATT CCAGAAGTAG TGAGGAGGCT 2101 TTTTTGGAGG CCTAGGCTTT TGCAAAAAGC TCCCGGGAGC TTGTATATCC ATTTTCGGAT 2161 CTGATCAGCA CGTGTTGACA ATTAATCATC GGCATAGTAT ATCGGCATAG TATAATACGA 2221 CAAGGTGAGG AACTAAACCA TGGCCAAGTT GACCAGTGCC GTTCCGGTGC TCACCGCGCG 2281 CGACGTCGCC GGAGCGGTCG AGTTCTGGAC CGACCGGCTC GGGTTCTCCC GGGACTTCGT 2341 GGAGGACGAC TTCGCCGGTG TGGTCCGGGA CGACGTGACC CTGTTCATCA GCGCGGTCCA 2401 GGACCAGGTG GTGCCGGACA ACACCCTGGC CTGGGTGTGG GTGCGCGGCC TGGACGAGCT 2461 GTACGCCGAG TGGTCGGAGG TCGTGTCCAC GAACTTCCGG GACGCCTCCG GGCCGGCCAT 2521 GACCGAGATC GGCGAGCAGC CGTGGGGGCG GGAGTTCGCC CTGCGCGACC CGGCCGGCAA 2581 CTGCGTGCAC TTCGTGGCCG AGGAGCAGGA CTGACACGTG CTACGAGATT TCGATTCCAC 2641 CGCCGCCTTC TATGAAAGGT TGGGCTTCGG AATCGTTTTC CGGGACGCCG GCTGGATGAT2701 CCTCCAGCGC GGGGATCTCA TGCTGGAGTT CTTCGCCCAC CCCAACTTGT TTATTGCAGC 2761 TTATAATGGT TACAAATAAA GCAATAGCAT CACAAATTTC ACAAATAAAG CATTTTTTTC 2821 ACTGCATTCT AGTTGTGGTT TGTCCAAACT CATCAATGTA TCTTATCATG TCTGTATACC 2881 GTCGACCTCT AGCTAGAGCT TGGCGTAATC ATGGTCATAG CTGTTTCCTG TGTGAAATTG 2941 TTATCCGCTC ACAATTCCAC ACAACATACG AGCCGGAAGC ATAAAGTGTA AAGCCTGGGG 3001 TGCCTAATGA GTGAGCTAAC TCACATTAAT TGCGTTGCGC TCACTGCCCG CTTTCCAGTC 3061 GGGAAACCTG TCGTGCCAGC TGCATTAATG AATCGGCCAA CGCGCGGGGA GAGGCGGTTT 3121 GCGTATTGGG CGCTCTTCCG CTTCCTCGCT CACTGACTCG CTGCGCTCGG TCGTTCGGCT 3181 GCGGCGAGCG GTATCAGCTC ACTCAAAGGC GGTAATACGG TTATCCACAG AATCAGGGGA 3241 TAACGCAGGA AAGAACATGT GAGCAAAAGG CCAGCAAAAG GCCAGGAACC GTAAAAAGGC 3301 CGCGTTGCTG GCGTTTTTCC ATAGGCTCCG CCCCCCTGAC GAGCATCACA AAAATCGACG 3361 CTCAAGTCAG AGGTGGCGAA ACCCGACAGG ACTATAAAGA TACCAGGCGT TTCCCCCTGG 3421 AAGCTCCCTC GTGCGCTCTC CTGTTCCGAC CCTGCCGCTT ACCGGATACC TGTCCGCCTT 3481 TCTCCCTTCG GGAAGCGTGG CGCTTTCTCA ATGCTCACGC TGTAGGTATC TCAGTTCGGT 3541 GTAGGTCGTT CGCTCCAAGC TGGGCTGTGT GCACGAACCC CCCGTTCAGC CCGACCGCTG 3601 CGCCTTATCC GGTAACTATC GTCTTGAGTC CAACCCGGTA AGACACGACT TATCGCCACT 3661 GGCAGCAGCC ACTGGTAACA GGATTAGCAG AGCGAGGTAT GTAGGCGGTG CTACAGAGTT 3721 CTTGAAGTGG TGGCCTAACT ACGGCTACAC TAGAAGGACA GTATTTGGTA TCTGCGCTCT 3781 GCTGAAGCCA GTTACCTTCG GAAAAAGAGT TGGTAGCTCT TGATCCGGCA AACAAACCAC 3841 CGCTGGTAGC GGTGGTTTTT TTGTTTGCAA GCAGCAGATT ACGCGCAGAA AAAAAGGATC 3901 TCAAGAAGAT CCTTTGATCT TTTCTACGGG GTCTGACGCT CAGTGGAACG AAAACTCACG 3961 TTAAGGGATT TTGGTCATGA GATTATCAAA AAGGATCTTC ACCTAGATCC TTTTAAATTA 4021 AAAATGAAGT TTTAAATCAA TCTAAAGTAT ATATGAGTAA ACTTGGTCTG ACAGTTACCA 4081 ATGCTTAATC AGTGAGGCAC CTATCTCAGC GATCTGTCTA TTTCGTTCAT CCATAGTTGC 4141 CTGACTCCCC GTCGTGTAGA TAACTACGAT ACGGGAGGGC TTACCATCTG GCCCCAGTGC 4201 TGCAATGATA CCGCGAGACC CACGCTCACC GGCTCCAGAT TTATCAGCAA TAAACCAGCC 4261 AGCCGGAAGG GCCGAGCGCA GAAGTGGTCC TGCAACTTTA TCCGCCTCCA TCCAGTCTAT 4321 TAATTGTTGC CGGGAAGCTA GAGTAAGTAG TTCGCCAGTT AATAGTTTGC GCAACGTTGT 4381 TGCCATTGCT ACAGGCATCG TGGTGTCACG CTCGTCGTTT GGTATGGCTT CATTCAGCTC 4441 CGGTTCCCAA CGATCAAGGC GAGTTACATG ATCCCCCATG TTGTGCAAAA AAGCGGTTAG 4501 CTCCTTCGGT CCTCCGATCG TTGTCAGAAG TAAGTTGGCC GCAGTGTTAT CACTCATGGT 4561 TATGGCAGCA CTGCATAATT CTCTTACTGT CATGCCATCC GTAAGATGCT TTTCTGTGAC 4621 TGGTGAGTAC TCAACCAAGT CATTCTGAGA ATAGTGTATG CGGCGACCGA GTTGCTCTTG 4681 CCCGGCGTCA ATACGGGATA ATACCGCGCC ACATAGCAGA ACTTTAAAAG TGCTCATCAT 4741 TGGAAAACGT TCTTCGGGGC GAAAACTCTC AAGGATCTTA CCGCTGTTGA GATCCAGTTC 4801 GATGTAACCC ACTCGTGCAC CCAACTGATC TTCAGCATCT TTTACTTTCA CCAGCGTTTC 4861 TGGGTGAGCA AAAACAGGAA GGCAAAATGC CGCAAAAAAG GGAATAAGGG CGACACGGAA 4921 ATGTTGAATA CTCATACTCT TCCTTTTTCA ATATTATTGA AGCATTTATC AGGGTTATTG 4981 TCTCATGAGC GGATACATAT TTGAATGTAT TTAGAAAAAT AAACAAATAG GGGTTCCGCG 5041 CACATTTCCC CGAAAAGTGC CACCTGACGT C//其他哺乳动物表达载体:pCHO1.0 pBApo-CMV-Pur pOPRSVIpcDNA3.1/His C pcDNA5/FRT/V5-His-TOPO pREP4pcDNA3.1/His B pcDNA5/FRT/TO-TOPO pDual-GCpcDNA3.1/His A pcDNA5/TO pBK-RSVpIRESpuro3 pcDNA5/FRT/TO pBK-CMVpIRES2-EGFP pcDNA5/FRT pBI-CMV4pTT5 pFLAG-CMV2 pcDNA4/TO/Myc-His/LacZ pNFkB-DD-tdTomato pcDNA3.1/CT-GFP-TOPO pOPI3CATpBI-CMV5 pcDNA3.1/NT-GFP-TOPO pGene/V5-His B pSEAP2-Basic pOptiVEC-TOPO pSwitchpSEAP2-Control pCMV-MEKK1 pCMVLacIpBI-CMV3 pCMV-MEK1 pVgRxRpBI-CMV2 pCMV-PKA pINDpBI-CMV1 pcDNA6.2/nTC-Tag-DEST pTRE3G-LucpNFκB-MetLuc2-Reporter pcDNA6.2/cTC-Tag-DEST pTRE3GpCRE-MetLuc2-Reporter pcDNA3.2/V5/GW/D-TOPO pTRE2-hygropAcGFP1-Actin pcDNA6.2/V5/GW/D-TOPO pTRE-TightpAcGFP1-N In-Fusion Ready pcDNA6.2/nGeneBLAzer-GW/D-TOPO pTK-hygpAcGFP1-C3 pcDNA6.2/C-YFP-DEST pTet-OnpAcGFP1-C pcDNA6.2/cGeneBLAzer-DEST pTet-OffpAcGFP1-p53 pcDNA6/V5-His A pTet on advanced pAcGFP1-Mito pcDNA6/V5-His B pRevTREpAcGFP1-Mem pcDNA6/V5-His C pRevTet-OnpAcGFP1-Lam pcDNA6/myc-His C pRevTet-OffpAcGFP1-Golgi pcDNA6/myc-His A pCMV-Tet3GpAcGFP1-F pcDNA6/myc-His B pTRE2pAcGFP1-Hyg-C1 pcDNA6.2/nGeneBLAzer-DEST pBD-NF-κBpAsRed2-N1 pcDNA4/HisMax-TOPO pCMV-ADptdTomato-N1 pcDNA6.2/nLumio-DEST pCMV-BDpCMV-tdTomato pcDNA6.2/cLumio-DEST pBIND-Id ControlpCRE-DD-tdTomato pcDNA4/myc-His C pBINDpCMV-DsRed-Express2 pcDNA4/HisMax C pG5 luciferasepEF1α-tdTomato pcDNA4/HisMax A pACT-MyoDpCRE-hrGFP c-Flag pcDNA3 pACTptdTomato-C1 pcDNA4/HisMax B pCMV-SPORT6 pAsRed2-C1 pcDNA4/myc-His B pGL4.13pGL3-Promoter pcDNA4/myc-His A pGL4.19pGL3 basic pcDNA4/His C pGL4.26pAcGFP1-C2 pcDNA4/His B pGL4.20pAcGFP1-C1 pcDNA4/His A pGL4.29pAcGFP1-N3 pcDNA6/TR pGL4.30pAcGFP1-N2 pcDNA4/TO/Myc-His A pGL4.27pAcGFP1-N1 pcDNA4/TO pGL4.75pAcGFP1-C In-Fusion Ready pcDNA4/TO/Myc-His B pGL4.10pCRE-DD-AmCyan1 pcDNA4/TO/Myc-His C pGRN145pNFkB-DD-AmCyan1 pcDNA3.3-TOPO pSecTag2 A pDsRed2-Bid pBudCE4.1 pEBVHis B pDsRED2-Mito pFLAG-CMV-4 pEBVHis ApDD-AmCyan1 Reporter pFLAG-CMV-3 pCMV-Tag 3C pAmCyan1-N1 pFLAG-CMV-2 pCMV-Tag 3A pAmCyan1-C1 pFLAG-CMV-5a pCMV-Tag 3BpEF1α-IRES-DsRed-Express2 p3XFLAG-CMV-9 pCMV-Tag 5CpEF1α-DsRed-Monomer-N1 p3xFLAG-CMV-10 pCMV-Tag 5A pDsRED-Monomer-N1 p3XFLAG-CMV-8 pCMV-Tag 4A pDsRed-Express-N1 p3XFLAG-CMV-7.1 pCMV-Tag 5Bp3XFLAG-CMV-7 pDsRed-Monomer-N In-Fusion Ready pCMV-Tag 4B pDsRed-Express-C1 p3XFLAG-CMV-13 pCMV-Tag 2C pIRES2-ZsGreen1 p3XFLAG-CMV-14 pCMV-Tag 2B pDsRed-Express2-C1 plRES2-ZsGreen1 pCMV-Tag 2A pDsRed-Express2-N1 pBApo-EF1α-pur pCMV-LacZpEF1α-DsRed-Express2 pBApo-EF1α-neo pCMV-MycpIRES2-DsRed-Express pBApo-CMV pEF1α-IRES-AcGFP1 pIRES2-DsRed-Express2 pBApo-CMV-neo pEF1α-IRES-ZsGreen1 pIRES-hrGFP-1a pIRES-EGFP pEF1α-AcGFP1-N1 pIRESneo2 pIRESneo3 pIRES2-DsRed2 pIRESneo pDsRed-Monomer pIRES2-AcGFP1 pIREShyg3 pIRES。
pcdna3
![pcdna3](https://img.taocdn.com/s3/m/fcba6882b1717fd5360cba1aa8114431b90d8e39.png)
pcdna3.4载体说明书
产品货号:HG-VPI0001
载体名称:pcDNA3、1(+)、pcDNA3、1+、pcDNA3、1
出品公司:Invitrogen
载体⽤途:哺乳动物表达载体
载体⽤⽤:5428bp
原核抗性:Ampicillin(氨苄青霉素)
真核筛选标记:Neomycin / G418
启动⽤:CMV promter
终⽤⽤:BGH poly(A) ignal
荧光标记:⽤
表达⽤式:组成型表达,⽤需诱导
表达⽤平:⽤
复制⽤:pUC ori
克隆菌株:DH5a、TOP10、L1-Blue等均可
载体拷贝数:⽤
5'测序引物:CMV-f(5’-CGCAAATGGGCGGTAGGCGTG-3’,测序公司免费提供)
3'测序引物:BGH-r(5’-TAGAAGGCACAGTCGAGG-3’,测序公司免费提供)
价格:询价
载体描述:
pcDNA3、1(+)是⽤前最常⽤的哺乳动物表达载体之⽤,载体使⽤CMV 强启动⽤调控外源基因的表达。
载体拷贝数很⽤,表达量也很⽤。
Amp+原核筛选抗性,Neo+真核筛选抗性,可以利⽤G418筛选稳定细胞株。
质粒图谱:。
哺乳动物细胞表达系统
![哺乳动物细胞表达系统](https://img.taocdn.com/s3/m/5b2022c7bb4cf7ec4afed012.png)
哺乳动物细胞表达系统按照宿主细胞的类型,可将基因表达系统大致分为原核、酵母、植物、昆虫和哺乳动物细胞表达系统。
与其它系统相比,哺乳动物细胞表达系统的优势在于能够指导蛋白质的正确折叠,提供复杂的N型糖基化和准确的O型糖基化等多种翻译后加工功能,因而表达产物在分子结构、理化特性和生物学功能方面最接近于天然的高等生物蛋白质分子。
从最开始以裸露DNA直接转染哺乳动物细胞至今的30余年间,哺乳动物细胞表达系统不仅已成为多种基因工程药物的生产平台,在新基因的发现、蛋白质的结构和功能研究中亦起了极为重要的作用。
本文主要从表达系统及其两个组成部分——表达载体和宿主细胞等方面,简要介绍哺乳动物细胞表达系统和相关的研究进展。
研究现状①部分蛋白在哺乳动物细胞中的表达已从实验室研究迈向生产或中试生产阶段。
②已有许多重要的蛋白及糖蛋白利用哺乳动物细胞系统表达和大量制备、生产。
如人组织型血纤蛋白酶原激活因子、凝血因子Ⅷ、干扰素、乙肝表面抗原、红血球生成激素、人生长激素、人抗凝血素Ⅲ,集落刺激因子等。
有些产品已投入临床应用或试用。
③虽然经过多年努力,哺乳动物细胞表达系统的表达水平有大幅度增高,但从整个水平上看仍偏低,一般处在杂交瘤细胞单克隆抗体蛋白产率的下限,即1-30μg/l08细胞/24小时。
有人认为其限速步骤可嚣是在工程细胞中(对于重组蛋白来讲,常是异源的),重组蛋白的分泌效率较低。
1 表达载体1.1 表达栽体的类型哺乳动物细胞表达外源重组蛋白可利用质粒转染和病毒载体的感染。
利用质粒转染获得稳定的转染细胞需几周甚至几个月时间,而利用病毒表达系统则可快速感染细胞,在几天内使外源基因整合到病毒载体中,尤其适用于从大量表达产物中检测出目的蛋白。
根据进入宿主细胞的方式,可将表达载体分为病毒载体与质粒载体。
病毒载体是以病毒颗粒的方式,通过病毒包膜蛋白与宿主细胞膜的相互作用使外源基因进入到细胞内。
常用的病毒载体有腺病毒、腺相关病毒、逆转录病毒、semliki森林病毒(sFv)载体等。
pDsRed2-Bid哺乳动物表达载体说明
![pDsRed2-Bid哺乳动物表达载体说明](https://img.taocdn.com/s3/m/7adf1f0c10a6f524ccbf854c.png)
pDsRed2-Bid编号 载体名称北京华越洋生物VECT6108 pDsRed2-‐BidpDsRed2-‐Bid载体基本信息载体名称: pDsRed2-Bid质粒类型: 哺乳动物细胞表达载体;信号通路报告载体高拷贝/低拷贝: 高拷贝克隆方法: 限制性内切酶,多克隆位点启动子: CMV IE载体大小: 5.3 kb5' 测序引物及序列: --3' 测序引物及序列: --载体标签: --载体抗性: 卡那霉素筛选标记: 新霉素(Neomycin)克隆菌株: DH5α, HB101宿主细胞(系): 常规细胞系,293、CV-1、CHO等备注: pDsRed2-Bid载体是红色荧光报告载体,用于研究依赖Bid的细胞凋亡信号通路。
稳定性: 瞬表达或稳表达组成型/诱导型: 组成型病毒/非病毒: 非病毒pDsRed2-‐Bid载体质粒图谱和多克隆位点信息pDsRed2-Bid载体描述pDsRed2-Bid is a mammalian expression vector that encodes a fusion of Discosoma sp. red fluorescent protein (DsRed2; 1, 2) and Bid, a member of the Bcl-2 “pro-apoptosis” family (3). Developed for our ApoAlert line, pDsRed2-Bid is designed to help researchers study Bid-dependent apoptosis pathways. Because of its fluorescent label, the Bid-DsRed2 fusion is easily detected by microscopy, allowing researchers to track its movements in response to certain apoptosis inducing agents (e.g., TNF-α).Bid’s activity is closely tied to its location in the cell. In healthy, non-apoptotic cells, Bid normally resides in the cytosol. But soon after the induction of apoptosis, it translocates to mitochondria, where it stimulates the release of cytochrome c—a key amplification step in the apoptotic cascade (4–7). The translocation is triggered by caspase-8, which, when activated by a death signal, cleaves Bid to produce a 15-kDa C-terminal fragment. The fragment, often referred to as truncated Bid or tBid, transmits the death signal further by translocating to the mitochondria. You can monitor this event visually by expressing Bid as a DsRed2 fusion. Bid-DsRed2, thefusion expressed by this vector, for example, emits red fluorescence—even after truncation—so it can be followed as it moves from the cytosol to the mitochondria. To drive expression of Bid-DsRed2, this vector contains the immediate early promoter of cytomegalovirus (PCMV IE), positioned just upstream of the Bid sequence. A short linker joins the Bid coding sequence to the 5'-end of DsRed2. Farther downstream, the vector contains a pair of SV40 polyadenylation signals, which direct proper processingof the 3'-end of the Bid-DsRed2 mRNA. The vector also contains an SV40 origin for replication in mammalian cells expressing the SV40 T antigen, a pUC origin of replication for propagation in E. coli, and an f1 origin for single-stranded DNA production. A neomycin-resistance cassette (Neor), consisting of the SV40 early promoter, the neomycin/kanamycin resistance gene of Tn5, and polyadenylation signals from the Herpes simplex virus thymidine kinase (HSV TK) gene, allows stably transfected eukaryotic cells to be selected using G418 (8). A bacterial promoter upstream of the cassette confers kanamycin resistance (Kanr) to E. coli.Cells transfected with pDsRed2-Bid constitutively express Bid as an N-terminal fusionto DsRed2. pDsRed2-Bid can be introduced into a variety of mammalian cell lines using any standard transfection method. If required, stable transfectants can be selected using G418 (8).Propagation in E. coliSuitable host strains: DH5α, HB101 and other general purpose strains. Single-stranded DNA production requiresa host containing an F plasmid such as JM109 or XL1-Blue.Selectable marker: plasmid confers resistance to kanamycin (50 μg/ml) to E. coli hosts.E. coli replication origin: pUCCopy number: ~500Plasmid incompatibility group: pMB1/ColE1Red Fluorescent Protein (DsRed2)Excitation/Emission Maxima: 558 nm / 583 nm其他哺乳动物表达载体:pCHO1.0 pBApo-CMV-Pur pOPRSVIpcDNA3.1/His C pcDNA5/FRT/V5-His-TOPO pREP4pcDNA3.1/His B pcDNA5/FRT/TO-TOPO pDual-GCpcDNA3.1/His A pcDNA5/TO pBK-RSVpIRESpuro3 pcDNA5/FRT/TO pBK-CMVpIRES2-EGFP pcDNA5/FRT pBI-CMV4pTT5 pFLAG-CMV2 pcDNA4/TO/Myc-His/LacZ pNFkB-DD-tdTomato pcDNA3.1/CT-GFP-TOPO pOPI3CATpBI-CMV5 pcDNA3.1/NT-GFP-TOPO pGene/V5-His B pSEAP2-Basic pOptiVEC-TOPO pSwitchpSEAP2-Control pCMV-MEKK1 pCMVLacIpBI-CMV3 pCMV-MEK1 pVgRxRpBI-CMV2 pCMV-PKA pINDpBI-CMV1 pcDNA6.2/nTC-Tag-DEST pTRE3G-Luc pNFκB-MetLuc2-Reporter pcDNA6.2/cTC-Tag-DEST pTRE3GpCRE-MetLuc2-Reporter pcDNA3.2/V5/GW/D-TOPO pTRE2-hygro pAcGFP1-Actin pcDNA6.2/V5/GW/D-TOPO pTRE-Tight pAcGFP1-N In-Fusion Ready pcDNA6.2/nGeneBLAzer-GW/D-TOPO pTK-hyg pAcGFP1-C3 pcDNA6.2/C-YFP-DEST pTet-On pAcGFP1-C pcDNA6.2/cGeneBLAzer-DEST pTet-Off pAcGFP1-p53 pcDNA6/V5-His A pTet on advanced pAcGFP1-Mito pcDNA6/V5-His B pRevTRE pAcGFP1-Mem pcDNA6/V5-His C pRevTet-On pAcGFP1-Lam pcDNA6/myc-His C pRevTet-Off pAcGFP1-Golgi pcDNA6/myc-His A pCMV-Tet3G pAcGFP1-F pcDNA6/myc-His B pTRE2 pAcGFP1-Hyg-C1 pcDNA6.2/nGeneBLAzer-DEST pBD-NF-κB pAsRed2-N1 pcDNA4/HisMax-TOPO pCMV-AD ptdTomato-N1 pcDNA6.2/nLumio-DEST pCMV-BD pCMV-tdTomato pcDNA6.2/cLumio-DEST pBIND-Id Control pCRE-DD-tdTomato pcDNA4/myc-His C pBINDpCMV-DsRed-Express2 pcDNA4/HisMax C pG5 luciferase pEF1α-tdTomato pcDNA4/HisMax A pACT-MyoD pCRE-hrGFP c-Flag pcDNA3 pACT ptdTomato-C1 pcDNA4/HisMax B pCMV-SPORT6 pAsRed2-C1 pcDNA4/myc-His B pGL4.13pGL3-Promoter pcDNA4/myc-His A pGL4.19pGL3 basic pcDNA4/His C pGL4.26 pAcGFP1-C2 pcDNA4/His B pGL4.20 pAcGFP1-C1 pcDNA4/His A pGL4.29 pAcGFP1-N3 pcDNA6/TR pGL4.30 pAcGFP1-N2 pcDNA4/TO/Myc-His A pGL4.27 pAcGFP1-N1 pcDNA4/TO pGL4.75 pAcGFP1-C In-Fusion Ready pcDNA4/TO/Myc-His B pGL4.10pCRE-DD-AmCyan1 pcDNA4/TO/Myc-His C pGRN145 pNFkB-DD-AmCyan1 pcDNA3.3-TOPO pSecTag2 A pDsRed2-Bid pBudCE4.1 pEBVHis B pDsRED2-Mito pFLAG-CMV-4 pEBVHis ApDD-AmCyan1 Reporter pFLAG-CMV-3 pCMV-Tag 3C pAmCyan1-N1 pFLAG-CMV-2 pCMV-Tag 3A pAmCyan1-C1 pFLAG-CMV-5a pCMV-Tag 3B pEF1α-IRES-DsRed-Express2 p3XFLAG-CMV-9 pCMV-Tag 5C pEF1α-DsRed-Monomer-N1 p3xFLAG-CMV-10 pCMV-Tag 5A pDsRED-Monomer-N1 p3XFLAG-CMV-8 pCMV-Tag 4ApDsRed-Express-N1 p3XFLAG-CMV-7.1 pCMV-Tag 5Bp3XFLAG-CMV-7 pDsRed-Monomer-N In-Fusion Ready pCMV-Tag 4B pDsRed-Express-C1 p3XFLAG-CMV-13 pCMV-Tag 2C pIRES2-ZsGreen1 p3XFLAG-CMV-14 pCMV-Tag 2B pDsRed-Express2-C1 plRES2-ZsGreen1 pCMV-Tag 2A pDsRed-Express2-N1 pBApo-EF1α-pur pCMV-LacZpEF1α-DsRed-Express2 pBApo-EF1α-neo pCMV-MycpIRES2-DsRed-Express pBApo-CMV pEF1α-IRES-AcGFP1 pIRES2-DsRed-Express2 pBApo-CMV-neo pEF1α-IRES-ZsGreen1 pIRES-hrGFP-1a pIRES-EGFP pEF1α-AcGFP1-N1 pIRESneo2 pIRESneo3 pIRES2-DsRed2 pIRESneo pDsRed-Monomer pIRES2-AcGFP1 pIREShyg3 pIRES。
GenePharma microRNA过表达载体使用说明书
![GenePharma microRNA过表达载体使用说明书](https://img.taocdn.com/s3/m/1fa570620622192e453610661ed9ad51f01d54a6.png)
上海吉玛制药技术有限公司 地址:上海浦东张江高科技园区哈雷路1011号 电话: 传真:苏州吉玛基因股份有限公司 地址:苏州工业园区东平街199号 电话:传真:电 话 : 苏 州 工 业 园 区 东 平 街 199 号电 话 :GenePharma microRNA 过表达载体使用说明书GenePharma MicroRNA 载体简介GenePharma MicroRNA-neg-control 实验设计在使用载体法针对某一MicroRNA 进行过表达研究过程中,通常会遇到如下几个问题:实验对照组的确立、细胞转染条件的确定、基因表达效率的检测。
1、 实验对照组的确立在一个完善的MicroRNA 表达实验设计中,必须考虑设立正确合理的实验对照组。
通常,这些对照组包括载体阴性对照组、转染试剂对照组。
载体阴性对照可以有两种,一种是采用通用的阴性对照组,在本试剂盒中包括了该对照所需的载体(microRNA ),可以表达与目的基因序列无同源性的microRNA 片段;另一种是将目的microRNA 的序列打乱后重新组合所得的阴性对照(scrambled )。
对照组的设立对于MicroRNA 表达研究是很有必要的,您可以利用载体对照来确认microRNA 实验中转染、RNA 提取和基因表达检测方法的可靠性。
本试剂盒中包括GenePharma MicroRNA-NC 过表达载体的对照,该载体在导入细胞中后,可以有效反应载体转染难易以及作为基因表达、RNA 提取、基因检测等系统参考。
2、 细胞转染条件的确定使用MicroRNA 载体转染细胞时,为了选择合适的转染方法和确定转染效率,通常采用报告基因来检测DNA 的导入情况。
最常用的报告基因是绿色荧光蛋白。
上海吉玛公司提供的MicroRNA 表达载体包含绿色荧光蛋白的表达框架,转入细胞后可以表达绿色荧光蛋白,用荧光显微镜或流式细胞仪可以很容易的确定转染效率。
3、 MicroRNA 表达的检测通常用两大类方法来检测MicroRNA 表达效率,一类方法是直接检测MicroRNA 的变化水平,常用的方法如northern 杂交、芯片(microarrays )以及核糖核酸酶保护分析,但这些传统的方法都需要用到标记探针与纯化的RNA 进行杂交,由于成熟的miRNAs 及其前体共享一段共同的靶序列,而且目前的这些方法有无法通过大小将其分开,因此很难专一识别成熟的MicroRNA ,导致较高的背景信号。
pTT5哺乳动物表达载体说明
![pTT5哺乳动物表达载体说明](https://img.taocdn.com/s3/m/1e84e914a6c30c2259019ea9.png)
pTT5编号 载体名称北京华越洋生物VECT6098 pTT5pTT5载体基本信息载体名称: pTT5质粒类型: 哺乳动物细胞载体高拷贝/低拷贝: 高拷贝克隆方法: 限制性内切酶,多克隆位点启动子: CMV载体大小: 4401 bp5' 测序引物及序列: CMV-F:CGCAAATGGGCGGTAGGCGTG 3' 测序引物及序列: --载体标签: 无载体抗性: 氨苄青霉素筛选标记: --克隆菌株: DH5α等宿主细胞(系): 常规细胞系(293、CV-1、CHO等)备注: 利用该质粒构建的基因表达是非融合表达,在构建质粒时需要在基因前面添加Kozak序列来增加蛋白表达效率。
稳定性: 瞬时表达组成型/诱导型: 诱导性病毒/非病毒: 非病毒pTT5载体质粒图谱和多克隆位点信息pTT5载体简介pTT5载体是很好的哺乳细胞瞬时蛋白表达载体,经常用于哺乳细胞的抗体轻链或者重链的表达。
pTT5载体序列ORIGIN1 GTACATTTAT ATTGGCTCAT GTCCAATATG ACCGCCATGT TGACATTGAT TATTGACTAG 61 TTATTAATAG TAATCAATTA CGGGGTCATT AGTTCATAGC CCATATATGG AGTTCCGCGT 121 TACATAACTT ACGGTAAATG GCCCGCCTGG CTGACCGCCC AACGACCCCC GCCCATTGAC 181 GTCAATAATG ACGTATGTTC CCATAGTAAC GCCAATAGGG ACTTTCCATT GACGTCAATG 241 GGTGGAGTAT TTACGGTAAA CTGCCCACTT GGCAGTACAT CAAGTGTATC ATATGCCAAG 301 TCCGCCCCCT ATTGACGTCA ATGACGGTAA ATGGCCCGCC TGGCATTATG CCCAGTACAT 361 GACCTTACGG GACTTTCCTA CTTGGCAGTA CATCTACGTA TTAGTCATCG CTATTACCAT 421 GGTGATGCGG TTTTGGCAGT ACACCAATGG GCGTGGATAG CGGTTTGACT CACGGGGATT 481 TCCAAGTCTC CACCCCATTG ACGTCAATGG GAGTTTGTTT TGGCACCAAA ATCAACGGGA 541 CTTTCCAAAA TGTCGTAATA ACCCCGCCCC GTTGACGCAA ATGGGCGGTA GGCGTGTACG 601 GTGGGAGGTC TATATAAGCA GAGCTCGTTT AGTGAACCGT CAGATCCTCA CTCTCTTCCG 661 CATCGCTGTC TGCGAGGGCC AGCTGTTGGG CTCGCGGTTG AGGACAAACT CTTCGCGGTC721 TTTCCAGTAC TCTTGGATCG GAAACCCGTC GGCCTCCGAA CGGTACTCCG CCACCGAGGG 781 ACCTGAGCGA GTCCGCATCG ACCGGATCGG AAAACCTCTC GAGAAAGGCG TCTAACCAGT 841 CACAGTCGCA AGGTAGGCTG AGCACCGTGG CGGGCGGCAG CGGGTGGCGG TCGGGGTTGT 901 TTCTGGCGGA GGTGCTGCTG ATGATGTAAT TAAAGTAGGC GGTCTTGAGA CGGCGGATGG 961 TCGAGGTGAG GTGTGGCAGG CTTGAGATCC AGCTGTTGGG GTGAGTACTC CCTCTCAAAA 1021 GCGGGCATTA CTTCTGCGCT AAGATTGTCA GTTTCCAAAA ACGAGGAGGA TTTGATATTC 1081 ACCTGGCCCG ATCTGGCCAT ACACTTGAGT GACAATGACA TCCACTTTGC CTTTCTCTCC 1141 ACAGGTGTCC ACTCCCAGGT CCAAGTTTAA ACGGATCTCT AGCGAATTCC CTCTAGAGGG 1201 CCCGTTTCTG CTAGCAAGCT TGCTAGCGGC CGCTCGAGGC CGGCAAGGCC GGATCCCCCG 1261 ACCTCGACCT CTGGCTAATA AAGGAAATTT ATTTTCATTG CAATAGTGTG TTGGAATTTT 1321 TTGTGTCTCT CACTCGGAAG GACATATGGG AGGGCAAATC ATTTGGTCGA GATCCCTCGG 1381 AGATCTCTAG CTAGAGGATC GATCCCCGCC CCGGACGAAC TAAACCTGAC TACGACATCT 1441 CTGCCCCTTC TTCGCGGGGC AGTGCATGTA ATCCCTTCAG TTGGTTGGTA CAACTTGCCA 1501 ACTGAACCCT AAACGGGTAG CATATGCTTC CCGGGTAGTA GTATATACTA TCCAGACTAA 1561 CCCTAATTCA ATAGCATATG TTACCCAACG GGAAGCATAT GCTATCGAAT TAGGGTTAGT 1621 AAAAGGGTCC TAAGGAACAG CGATGTAGGT GGGCGGGCCA AGATAGGGGC GCGATTGCTG 1681 CGATCTGGAG GACAAATTAC ACACACTTGC GCCTGAGCGC CAAGCACAGG GTTGTTGGTC 1741 CTCATATTCA CGAGGTCGCT GAGAGCACGG TGGGCTAATG TTGCCATGGG TAGCATATAC 1801 TACCCAAATA TCTGGATAGC ATATGCTATC CTAATCTATA TCTGGGTAGC ATAGGCTATC 1861 CTAATCTATA TCTGGGTAGC ATATGCTATC CTAATCTATA TCTGGGTAGT ATATGCTATC 1921 CTAATTTATA TCTGGGTAGC ATAGGCTATC CTAATCTATA TCTGGGTAGC ATATGCTATC 1981 CTAATCTATA TCTGGGTAGT ATATGCTATC CTAATCTGTA TCCGGGTAGC ATATGCTATC 2041 CTAATAGAGA TTAGGGTAGT ATATGCTATC CTAATTTATA TCTGGGTAGC ATATACTACC 2101 CAAATATCTG GATAGCATAT GCTATCCTAA TCTATATCTG GGTAGCATAT GCTATCCTAA 2161 TCTATATCTG GGTAGCATAG GCTATCCTAA TCTATATCTG GGTAGCATAT GCTATCCTAA 2221 TCTATATCTG GGTAGTATAT GCTATCCTAA TTTATATCTG GGTAGCATAG GCTATCCTAA 2281 TCTATATCTG GGTAGCATAT GCTATCCTAA TCTATATCTG GGTAGTATAT GCTATCCTAA 2341 TCTGTATCCG GGTAGCATAT GCTATCCTCA TGATAAGCTG TCAAACATGA GAATTAATTC 2401 TTGAAGACGA AAGGGCCTCG TGATACGCCT ATTTTTATAG GTTAATGTCA TGATAATAAT 2461 GGTTTCTTAG ACGTCAGGTG GCACTTTTCG GGGAAATGTG CGCGGAACCC CTATTTGTTT 2521 ATTTTTCTAA ATACATTCAA ATATGTATCC GCTCATGAGA CAATAACCCT GATAAATGCT 2581 TCAATAATAT TGAAAAAGGA AGAGTATGAG TATTCAACAT TTCCGTGTCG CCCTTATTCC 2641 CTTTTTTGCG GCATTTTGCC TTCCTGTTTT TGCTCACCCA GAAACGCTGG TGAAAGTAAA 2701 AGATGCTGAA GATCAGTTGG GTGCACGAGT GGGTTACATC GAACTGGATC TCAACAGCGG 2761 TAAGATCCTT GAGAGTTTTC GCCCCGAAGA ACGTTTTCCA ATGATGAGCA CTTTTAAAGT 2821 TCTGCTATGT GGCGCGGTAT TATCCCGTGT TGACGCCGGG CAAGAGCAAC TCGGTCGCCG 2881 CATACACTAT TCTCAGAATG ACTTGGTTGA GTACTCACCA GTCACAGAAA AGCATCTTAC 2941 GGATGGCATG ACAGTAAGAG AATTATGCAG TGCTGCCATA ACCATGAGTG ATAACACTGC 3001 GGCCAACTTA CTTCTGACAA CGATCGGAGG ACCGAAGGAG CTAACCGCTT TTTTGCACAA 3061 CATGGGGGAT CATGTAACTC GCCTTGATCG TTGGGAACCG GAGCTGAATG AAGCCATACC 3121 AAACGACGAG CGTGACACCA CGATGCCTGC AGCAATGGCA ACAACGTTGC GCAAACTATT 3181 AACTGGCGAA CTACTTACTC TAGCTTCCCG GCAACAATTA ATAGACTGGA TGGAGGCGGA 3241 TAAAGTTGCA GGACCACTTC TGCGCTCGGC CCTTCCGGCT GGCTGGTTTA TTGCTGATAA 3301 ATCTGGAGCC GGTGAGCGTG GGTCTCGCGG TATCATTGCA GCACTGGGGC CAGATGGTAA3361 GCCCTCCCGT ATCGTAGTTA TCTACACGAC GGGGAGTCAG GCAACTATGG ATGAACGAAA3421 TAGACAGATC GCTGAGATAG GTGCCTCACT GATTAAGCAT TGGTAACTGT CAGACCAAGT3481 TTACTCATAT ATACTTTAGA TTGATTTAAA ACTTCATTTT TAATTTAAAA GGATCTAGGT3541 GAAGATCCTT TTTGATAATC TCATGACCAA AATCCCTTAA CGTGAGTTTT CGTTCCACTG3601 AGCGTCAGAC CCCGTAGAAA AGATCAAAGG ATCTTCTTGA GATCCTTTTT TTCTGCGCGT3661 AATCTGCTGC TTGCAAACAA AAAAACCACC GCTACCAGCG GTGGTTTGTT TGCCGGATCA3721 AGAGCTACCA ACTCTTTTTC CGAAGGTAAC TGGCTTCAGC AGAGCGCAGA TACCAAATAC3781 TGTTCTTCTA GTGTAGCCGT AGTTAGGCCA CCACTTCAAG AACTCTGTAG CACCGCCTAC3841 ATACCTCGCT CTGCTAATCC TGTTACCAGT GGCTGCTGCC AGTGGCGATA AGTCGTGTCT3901 TACCGGGTTG GACTCAAGAC GATAGTTACC GGATAAGGCG CAGCGGTCGG GCTGAACGGG3961 GGGTTCGTGC ACACAGCCCA GCTTGGAGCG AACGACCTAC ACCGAACTGA GATACCTACA4021 GCGTGAGCTA TGAGAAAGCG CCACGCTTCC CGAAGGGAGA AAGGCGGACA GGTATCCGGT4081 AAGCGGCAGG GTCGGAACAG GAGAGCGCAC GAGGGAGCTT CCAGGGGGAA ACGCCTGGTA4141 TCTTTATAGT CCTGTCGGGT TTCGCCACCT CTGACTTGAG CGTCGATTTT TGTGATGCTC4201 GTCAGGGGGG CGGAGCCTAT GGAAAAACGC CAGCAACGCG GCCTTTTTAC GGTTCCTGGC4261 CTTTTGCTGG CCTTTTGCTC ACATGTTCTT TCCTGCGTTA TCCCCTGATT CTGTGGATAA4321 CCGTATTACC GCCTTTGAGT GAGCTGATAC CGCTCGCCGC AGCCGAACGA CCGAGCGCAG4381 CGAGTCAGTG AGCGAGGAAG C//其他哺乳动物表达载体:pCHO1.0 pBApo-CMV-Pur pOPRSVIpcDNA3.1/His C pcDNA5/FRT/V5-His-TOPO pREP4pcDNA3.1/His B pcDNA5/FRT/TO-TOPO pDual-GCpcDNA3.1/His A pcDNA5/TO pBK-RSVpIRESpuro3 pcDNA5/FRT/TO pBK-CMVpIRES2-EGFP pcDNA5/FRT pBI-CMV4pTT5 pFLAG-CMV2 pcDNA4/TO/Myc-His/LacZ pNFkB-DD-tdTomato pcDNA3.1/CT-GFP-TOPO pOPI3CATpBI-CMV5 pcDNA3.1/NT-GFP-TOPO pGene/V5-His B pSEAP2-Basic pOptiVEC-TOPO pSwitchpSEAP2-Control pCMV-MEKK1 pCMVLacIpBI-CMV3 pCMV-MEK1 pVgRxRpBI-CMV2 pCMV-PKA pINDpBI-CMV1 pcDNA6.2/nTC-Tag-DEST pTRE3G-LucpNFκB-MetLuc2-Reporter pcDNA6.2/cTC-Tag-DEST pTRE3GpCRE-MetLuc2-Reporter pcDNA3.2/V5/GW/D-TOPO pTRE2-hygropAcGFP1-Actin pcDNA6.2/V5/GW/D-TOPO pTRE-TightpAcGFP1-N In-Fusion Ready pcDNA6.2/nGeneBLAzer-GW/D-TOPO pTK-hygpAcGFP1-C3 pcDNA6.2/C-YFP-DEST pTet-OnpAcGFP1-C pcDNA6.2/cGeneBLAzer-DEST pTet-OffpAcGFP1-p53 pcDNA6/V5-His A pTet on advanced pAcGFP1-Mito pcDNA6/V5-His B pRevTREpAcGFP1-Mem pcDNA6/V5-His C pRevTet-OnpAcGFP1-Lam pcDNA6/myc-His C pRevTet-Off pAcGFP1-Golgi pcDNA6/myc-His A pCMV-Tet3G pAcGFP1-F pcDNA6/myc-His B pTRE2pAcGFP1-Hyg-C1 pcDNA6.2/nGeneBLAzer-DEST pBD-NF-κB pAsRed2-N1 pcDNA4/HisMax-TOPO pCMV-AD ptdTomato-N1 pcDNA6.2/nLumio-DEST pCMV-BDpCMV-tdTomato pcDNA6.2/cLumio-DEST pBIND-Id Control pCRE-DD-tdTomato pcDNA4/myc-His C pBINDpCMV-DsRed-Express2 pcDNA4/HisMax C pG5 luciferasepEF1α-tdTomato pcDNA4/HisMax A pACT-MyoDpCRE-hrGFP c-Flag pcDNA3 pACTptdTomato-C1 pcDNA4/HisMax B pCMV-SPORT6 pAsRed2-C1 pcDNA4/myc-His B pGL4.13pGL3-Promoter pcDNA4/myc-His A pGL4.19pGL3 basic pcDNA4/His C pGL4.26pAcGFP1-C2 pcDNA4/His B pGL4.20pAcGFP1-C1 pcDNA4/His A pGL4.29pAcGFP1-N3 pcDNA6/TR pGL4.30pAcGFP1-N2 pcDNA4/TO/Myc-His A pGL4.27pAcGFP1-N1 pcDNA4/TO pGL4.75pAcGFP1-C In-Fusion Ready pcDNA4/TO/Myc-His B pGL4.10pCRE-DD-AmCyan1 pcDNA4/TO/Myc-His C pGRN145pNFkB-DD-AmCyan1 pcDNA3.3-TOPO pSecTag2 A pDsRed2-Bid pBudCE4.1 pEBVHis B pDsRED2-Mito pFLAG-CMV-4 pEBVHis ApDD-AmCyan1 Reporter pFLAG-CMV-3 pCMV-Tag 3C pAmCyan1-N1 pFLAG-CMV-2 pCMV-Tag 3A pAmCyan1-C1 pFLAG-CMV-5a pCMV-Tag 3BpEF1α-IRES-DsRed-Express2 p3XFLAG-CMV-9 pCMV-Tag 5CpEF1α-DsRed-Monomer-N1 p3xFLAG-CMV-10 pCMV-Tag 5A pDsRED-Monomer-N1 p3XFLAG-CMV-8 pCMV-Tag 4A pDsRed-Express-N1 p3XFLAG-CMV-7.1 pCMV-Tag 5Bp3XFLAG-CMV-7 pDsRed-Monomer-N In-Fusion Ready pCMV-Tag 4B pDsRed-Express-C1 p3XFLAG-CMV-13 pCMV-Tag 2C pIRES2-ZsGreen1 p3XFLAG-CMV-14 pCMV-Tag 2B pDsRed-Express2-C1 plRES2-ZsGreen1 pCMV-Tag 2A pDsRed-Express2-N1 pBApo-EF1α-pur pCMV-LacZpEF1α-DsRed-Express2 pBApo-EF1α-neo pCMV-MycpIRES2-DsRed-Express pBApo-CMV pEF1α-IRES-AcGFP1 pIRES2-DsRed-Express2 pBApo-CMV-neo pEF1α-IRES-ZsGreen1 pIRES-hrGFP-1a pIRES-EGFP pEF1α-AcGFP1-N1 pIRESneo2 pIRESneo3 pIRES2-DsRed2 pIRESneo pDsRed-Monomer pIRES2-AcGFP1 pIREShyg3 pIRES。
pCHO1.0哺乳动物表达载体说明
![pCHO1.0哺乳动物表达载体说明](https://img.taocdn.com/s3/m/8e0f866d31b765ce05081437.png)
pCHO1.0编号 载体名称北京华越洋生物VECT6001 pCHO1.0pCHO1.0载体基本信息载体名称: pCHO1.0质粒类型: 哺乳动物细胞表达载体, 哺乳动物细胞稳定细胞系建立载体 启动子: CMV表达水平: 高克隆方法: 多克隆位点,限制性内切酶载体大小: 12988 b p5' 测序引物: AB-‐F: G TCTGAGCCTCCTTGTCTTG; EP-‐F:GGTGTCGTGAGGAATTTCAG3' 测序引物: AB-‐R: A GAAGACACGGGAGACTTAG; EP-‐R: G AGGCAGCCGGATCATAATC载体标签: /载体抗性: 卡那筛选标记: Puromycin, DHFR备注: -‐-‐稳定性: 稳表达组成型: 组成型 Constitutive病毒/非病毒: 非病毒pCHO1.0载体质粒图谱和多克隆位点信息pCHO1.0载体简介pCHO 1.0载体是能够表达一个基因或利用载体上面的杂交CMV启动子共表达2个目的基因。
该载体包含有二氢叶酸还原酶(DHFR)选择性标记和嘌呤霉素(puromycin)抗性基因,可以同时使用MTX和嘌呤霉素进行筛选。
其他哺乳动物表达载体:pCHO1.0 pBApo-CMV-Pur pOPRSVIpcDNA3.1/His C pcDNA5/FRT/V5-His-TOPO pREP4pcDNA3.1/His B pcDNA5/FRT/TO-TOPO pDual-GCpcDNA3.1/His A pcDNA5/TO pBK-RSVpIRESpuro3 pcDNA5/FRT/TO pBK-CMVpIRES2-EGFP pcDNA5/FRT pBI-CMV4pTT5 pFLAG-CMV2 pcDNA4/TO/Myc-His/LacZ pNFkB-DD-tdTomato pcDNA3.1/CT-GFP-TOPO pOPI3CATpBI-CMV5 pcDNA3.1/NT-GFP-TOPO pGene/V5-His BpSEAP2-Basic pOptiVEC-TOPO pSwitchpSEAP2-Control pCMV-MEKK1 pCMVLacIpBI-CMV3 pCMV-MEK1 pVgRxRpBI-CMV2 pCMV-PKA pINDpBI-CMV1 pcDNA6.2/nTC-Tag-DEST pTRE3G-LucpNFκB-MetLuc2-Reporter pcDNA6.2/cTC-Tag-DEST pTRE3GpCRE-MetLuc2-Reporter pcDNA3.2/V5/GW/D-TOPO pTRE2-hygropAcGFP1-Actin pcDNA6.2/V5/GW/D-TOPO pTRE-TightpAcGFP1-N In-Fusion Ready pcDNA6.2/nGeneBLAzer-GW/D-TOPO pTK-hygpAcGFP1-C3 pcDNA6.2/C-YFP-DEST pTet-OnpAcGFP1-C pcDNA6.2/cGeneBLAzer-DEST pTet-OffpAcGFP1-p53 pcDNA6/V5-His A pTet on advanced pAcGFP1-Mito pcDNA6/V5-His B pRevTREpAcGFP1-Mem pcDNA6/V5-His C pRevTet-OnpAcGFP1-Lam pcDNA6/myc-His C pRevTet-OffpAcGFP1-Golgi pcDNA6/myc-His A pCMV-Tet3GpAcGFP1-F pcDNA6/myc-His B pTRE2pAcGFP1-Hyg-C1 pcDNA6.2/nGeneBLAzer-DEST pBD-NF-κBpAsRed2-N1 pcDNA4/HisMax-TOPO pCMV-ADptdTomato-N1 pcDNA6.2/nLumio-DEST pCMV-BDpCMV-tdTomato pcDNA6.2/cLumio-DEST pBIND-Id ControlpCRE-DD-tdTomato pcDNA4/myc-His C pBINDpCMV-DsRed-Express2 pcDNA4/HisMax C pG5 luciferasepEF1α-tdTomato pcDNA4/HisMax A pACT-MyoDpCRE-hrGFP c-Flag pcDNA3 pACTptdTomato-C1 pcDNA4/HisMax B pCMV-SPORT6pAsRed2-C1 pcDNA4/myc-His B pGL4.13pGL3-Promoter pcDNA4/myc-His A pGL4.19pGL3 basic pcDNA4/His C pGL4.26pAcGFP1-C2 pcDNA4/His B pGL4.20pAcGFP1-C1 pcDNA4/His A pGL4.29pAcGFP1-N3 pcDNA6/TR pGL4.30pAcGFP1-N2 pcDNA4/TO/Myc-His A pGL4.27pAcGFP1-N1 pcDNA4/TO pGL4.75pAcGFP1-C In-Fusion Ready pcDNA4/TO/Myc-His B pGL4.10pCRE-DD-AmCyan1 pcDNA4/TO/Myc-His C pGRN145pNFkB-DD-AmCyan1 pcDNA3.3-TOPO pSecTag2 A pDsRed2-Bid pBudCE4.1 pEBVHis B pDsRED2-Mito pFLAG-CMV-4 pEBVHis ApDD-AmCyan1 Reporter pFLAG-CMV-3 pCMV-Tag 3C pAmCyan1-N1 pFLAG-CMV-2 pCMV-Tag 3A pAmCyan1-C1 pFLAG-CMV-5a pCMV-Tag 3BpEF1α-IRES-DsRed-Express2 p3XFLAG-CMV-9 pCMV-Tag 5CpEF1α-DsRed-Monomer-N1 p3xFLAG-CMV-10 pCMV-Tag 5A pDsRED-Monomer-N1 p3XFLAG-CMV-8 pCMV-Tag 4A pDsRed-Express-N1 p3XFLAG-CMV-7.1 pCMV-Tag 5Bp3XFLAG-CMV-7 pDsRed-Monomer-N In-Fusion Ready pCMV-Tag 4B pDsRed-Express-C1 p3XFLAG-CMV-13 pCMV-Tag 2C pIRES2-ZsGreen1 p3XFLAG-CMV-14 pCMV-Tag 2B pDsRed-Express2-C1 plRES2-ZsGreen1 pCMV-Tag 2A pDsRed-Express2-N1 pBApo-EF1α-pur pCMV-LacZpEF1α-DsRed-Express2 pBApo-EF1α-neo pCMV-MycpIRES2-DsRed-Express pBApo-CMV pEF1α-IRES-AcGFP1 pIRES2-DsRed-Express2 pBApo-CMV-neo pEF1α-IRES-ZsGreen1 pIRES-hrGFP-1a pIRES-EGFP pEF1α-AcGFP1-N1 pIRESneo2 pIRESneo3 pIRES2-DsRed2 pIRESneo pDsRed-Monomer pIRES2-AcGFP1 pIREShyg3 pIRES。
pCMV-LacZ哺乳动物表达载体说明
![pCMV-LacZ哺乳动物表达载体说明](https://img.taocdn.com/s3/m/0c0691e9c8d376eeaeaa3142.png)
pCMV-LacZ编号 载体名称北京华越洋生物VECT6133 pCMV-‐LacZpCMV-‐LacZ 载体基本信息 载体名称: pCMV-LacZ 质粒类型: 哺乳动物表达载体;β-gal 报告载体 高拷贝/低拷贝: 高拷贝 克隆方法: -- 启动子: CMV 载体大小: 7.2 kb 5' 测序引物及序列: CMV Forward CGCAAATGGGCGGTAGGCGTG 3' 测序引物及序列: -- 载体标签: -- 载体抗性: 氨苄青霉素 筛选标记: 无 克隆菌株: DH5a 或 HB101 宿主细胞(系): --备注:pCMV-LacZ 载体是β半乳糖甘酶表达载体,在哺乳动物细胞中高水平表达β半乳糖甘酶;可用于建立标准浓度或者标准菌株,定量分析其它报告型载体的表达情况。
稳定性: 瞬表达 组成型/诱导型: 组成型 病毒/非病毒: 非病毒pCMV-‐LacZ 载体质粒图谱和多克隆位点信息pCMV-‐LacZ载体简介pCMV-LacZ is a mammalian reporter vector designed to expression β-galactosidasein mammalian cells from the human cytomegalovirus immediate early gene promoter (1). pCMV-LacZ contains an intron (splice donor/splice acceptor; 2) and polyadenylation signal from SV40, and the full-length E. coli β-galactosidase gene with eukaryotic translation initiation signals (3). pCMV-LacZ expresses high levels ofβ-galactosidase and can be used as a reference (control) plasmid when transfecting other reporter gene constructs and can be used to optimize transfection protocols by employing standard assays or stains to assay β-galactosidase activity. Alternatively,the β-galactosidase gene can be excised using the Not I sites at each end to allow other genes to be inserted into the pCMV-LacZ vector backbone for expression in mammalian cells or to insert the β-galactosidase fragment into another expression vector.pCMV-‐LacZ其他哺乳动物表达载体:pCHO1.0 pBApo-CMV-Pur pOPRSVIpcDNA3.1/His C pcDNA5/FRT/V5-His-TOPO pREP4pcDNA3.1/His B pcDNA5/FRT/TO-TOPO pDual-GCpcDNA3.1/His A pcDNA5/TO pBK-RSVpIRESpuro3 pcDNA5/FRT/TO pBK-CMVpIRES2-EGFP pcDNA5/FRT pBI-CMV4pTT5 pFLAG-CMV2 pcDNA4/TO/Myc-His/LacZ pNFkB-DD-tdTomato pcDNA3.1/CT-GFP-TOPO pOPI3CATpBI-CMV5 pcDNA3.1/NT-GFP-TOPO pGene/V5-His B pSEAP2-Basic pOptiVEC-TOPO pSwitchpSEAP2-Control pCMV-MEKK1 pCMVLacIpBI-CMV3 pCMV-MEK1 pVgRxRpBI-CMV2 pCMV-PKA pINDpBI-CMV1 pcDNA6.2/nTC-Tag-DEST pTRE3G-Luc pNFκB-MetLuc2-Reporter pcDNA6.2/cTC-Tag-DEST pTRE3GpCRE-MetLuc2-Reporter pcDNA3.2/V5/GW/D-TOPO pTRE2-hygro pAcGFP1-Actin pcDNA6.2/V5/GW/D-TOPO pTRE-Tight pAcGFP1-N In-Fusion Ready pcDNA6.2/nGeneBLAzer-GW/D-TOPO pTK-hyg pAcGFP1-C3 pcDNA6.2/C-YFP-DEST pTet-On pAcGFP1-C pcDNA6.2/cGeneBLAzer-DEST pTet-Off pAcGFP1-p53 pcDNA6/V5-His A pTet on advanced pAcGFP1-Mito pcDNA6/V5-His B pRevTRE pAcGFP1-Mem pcDNA6/V5-His C pRevTet-On pAcGFP1-Lam pcDNA6/myc-His C pRevTet-Off pAcGFP1-Golgi pcDNA6/myc-His A pCMV-Tet3G pAcGFP1-F pcDNA6/myc-His B pTRE2 pAcGFP1-Hyg-C1 pcDNA6.2/nGeneBLAzer-DEST pBD-NF-κB pAsRed2-N1 pcDNA4/HisMax-TOPO pCMV-AD ptdTomato-N1 pcDNA6.2/nLumio-DEST pCMV-BD pCMV-tdTomato pcDNA6.2/cLumio-DEST pBIND-Id Control pCRE-DD-tdTomato pcDNA4/myc-His C pBINDpCMV-DsRed-Express2 pcDNA4/HisMax C pG5 luciferase pEF1α-tdTomato pcDNA4/HisMax A pACT-MyoD pCRE-hrGFP c-Flag pcDNA3 pACT ptdTomato-C1 pcDNA4/HisMax B pCMV-SPORT6 pAsRed2-C1 pcDNA4/myc-His B pGL4.13pGL3-Promoter pcDNA4/myc-His A pGL4.19pGL3 basic pcDNA4/His C pGL4.26 pAcGFP1-C2 pcDNA4/His B pGL4.20 pAcGFP1-C1 pcDNA4/His A pGL4.29 pAcGFP1-N3 pcDNA6/TR pGL4.30 pAcGFP1-N2 pcDNA4/TO/Myc-His A pGL4.27 pAcGFP1-N1 pcDNA4/TO pGL4.75 pAcGFP1-C In-Fusion Ready pcDNA4/TO/Myc-His B pGL4.10pCRE-DD-AmCyan1 pcDNA4/TO/Myc-His C pGRN145 pNFkB-DD-AmCyan1 pcDNA3.3-TOPO pSecTag2 A pDsRed2-Bid pBudCE4.1 pEBVHis B pDsRED2-Mito pFLAG-CMV-4 pEBVHis ApDD-AmCyan1 Reporter pFLAG-CMV-3 pCMV-Tag 3C pAmCyan1-N1 pFLAG-CMV-2 pCMV-Tag 3A pAmCyan1-C1 pFLAG-CMV-5a pCMV-Tag 3B pEF1α-IRES-DsRed-Express2 p3XFLAG-CMV-9 pCMV-Tag 5C pEF1α-DsRed-Monomer-N1 p3xFLAG-CMV-10 pCMV-Tag 5A pDsRED-Monomer-N1 p3XFLAG-CMV-8 pCMV-Tag 4A pDsRed-Express-N1 p3XFLAG-CMV-7.1 pCMV-Tag 5Bp3XFLAG-CMV-7 pDsRed-Monomer-N In-Fusion Ready pCMV-Tag 4B pDsRed-Express-C1 p3XFLAG-CMV-13 pCMV-Tag 2CpIRES2-ZsGreen1 p3XFLAG-CMV-14 pCMV-Tag 2B pDsRed-Express2-C1 plRES2-ZsGreen1 pCMV-Tag 2A pDsRed-Express2-N1 pBApo-EF1α-pur pCMV-LacZpEF1α-DsRed-Express2 pBApo-EF1α-neo pCMV-MycpIRES2-DsRed-Express pBApo-CMV pEF1α-IRES-AcGFP1 pIRES2-DsRed-Express2 pBApo-CMV-neo pEF1α-IRES-ZsGreen1 pIRES-hrGFP-1a pIRES-EGFP pEF1α-AcGFP1-N1 pIRESneo2 pIRESneo3 pIRES2-DsRed2 pIRESneo pDsRed-Monomer pIRES2-AcGFP1 pIREShyg3 pIRES。
目的基因过表达质粒
![目的基因过表达质粒](https://img.taocdn.com/s3/m/a23ff218f011f18583d049649b6648d7c1c708e7.png)
目的基因过表达质粒目的基因过表达质粒是一种重要的分子生物学工具,广泛应用于基因工程和基因治疗研究中。
在此篇文章中,我们将从以下几个方面来详细介绍它的使用及操作步骤。
第一步:挑选合适的质粒对于目的基因过表达,选择合适的质粒是至关重要的。
选择时需要考虑到质粒的大小、载体种类、质粒拷贝数、选择标记以及基因表达水平等因素,并根据实验目的进行筛选。
其中,载体种类是一个值得考虑的主要因素。
常见的载体包括pCMV、pUC、pcDNA等。
pCMV适合转导哺乳动物细胞,pUC适合转化大肠杆菌等经典菌,pcDNA则适用于哺乳动物细胞和真核细胞。
第二步:构建适合实验的质粒在挑选好适合的质粒后,下一步是构建适合实验的质粒。
对于建立目的基因过表达的质粒,需要将要过表达的基因插入到质粒中的适当位置,通常是插入在多克隆位点后,而且需要考虑适当的启动子,不同启动子的效率不同。
伴随着分子克隆技术的不断革新,现在也可以通过基因合成来构建完整的适合实验的质粒。
基因合成可以在无需基因片段的情况下生成目的基因序列,并将其插入到易于转化的质粒中。
第三步:正确的转染正确的转染是目的基因过表达质粒发挥作用的关键。
一般来说,有多种方法可供选择,包括离子磷脂体介导转染、电穿孔法、微弱电流法以及病毒载体介导转染等。
对于哺乳动物细胞的转染,离子磷脂体介导转染是一种简单、方便且有效的方法。
它通过将质粒与离子磷脂体配合,形成了一种稳定的复合物,通过细胞膜的缺陷或者微小通道进入到细胞内,实现目的基因的转录和翻译。
第四步:筛选成功的细胞一旦我们成功进行了转染,接下来需要筛选出质粒成功过表达目的基因的细胞。
方法包括荧光检测、药物筛选、PCR检测等。
其中,荧光检测是基因定位和表达分析的非常好的方法,通过荧光量和图像分析可以定量反映目的基因的表达。
药物筛选则是针对存在选择标记的质粒,利用该标记的选择性作用,对质粒果予以筛选,优选有目的基因过表达的细胞。
总之,目的基因过表达质粒是基因工程和基因治疗领域中重要的分子工具,准确地进行实验操作,能够为科学研究提供基础数据和技术指导,为相关领域的人员奠定一个更加坚实的基础。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
pcDNA5/TO编号 载体名称北京华越洋生物VECT6166 pcDNA5/TOpcDNA5/TO载体基本信息载体名称: pcDNA5/TO质粒类型: 哺乳动物细胞表达载体;cDNA表达载体;四环素调控载体高拷贝/低拷贝: 高拷贝克隆方法: 限制性内切酶,多克隆位点启动子: CMVTO载体大小: 5667 bp5' 测序引物及序列: --3' 测序引物及序列: --载体标签: 无标签载体抗性: 氨苄青霉素筛选标记: 潮霉素(Hygromycin)克隆菌株: TOP10 ,DH5-T1R宿主细胞(系): Invitrogen公司出品的T-REx细胞系,293、Hella、CHO、Jurkat等备注: pcDNA5/TO载体是cDNA的表达与克隆载体;CMVTO启动子受四环素调控;pcDNA5/TO载体作为应答载体与调控载体pcDNA6/TR共同使用。
稳定性: 瞬表达或稳表达组成型/诱导型: 诱导型病毒/非病毒: 非病毒pcDNA5/TO载体质粒图谱和多克隆位点信息pcDNA5/TO载体简介pcDNA5/TO is a 5.7 kb expression vector designed for use with the T-REx System (Catalog Nos. K1020-01 and K1020-02) available from Life Technologies. The vector allows tetracycline-regulated expression of the gene of interest in mammalian host cells expressing the Tet repressor (TetR) from the pcDNA6/TR vector (Catalog No. V1025-20). The T-REx System yields higher levels of induced expression than any other regulated mammalian expression system. It utilizes the complete CMV promoter and adds control elements from the bacterial tetracycline resistance operon to effectively repress and derepress transcription from one of the strongest mammalian promoter sequences known.pcDNA5/TO 载体含有以下元件:Hybrid promoter consisting of the human cytomegalovirus immediate-early (CMV) promoter and tetracycline operator 2 (TetO2) sites for high-level tetracycline-regulated expression in a wide range of mammalian cellsHygromycin resistance gene for selection of stable cell lines The control plasmid, pcDNA5/TO/lacZ, is included for use as a positive control for transfection and tetracycline-regulated expression in the cell line of choice.关于pcDNA5/TO 载体的注意事项The pcDNA5/TO vector contains two tetracycline operator 2 (TetO2) sites within the human cytomegalovirus immediate-early (CMV) promoter for tetracyclineregulated expression of your gene of interest (Yao et al., 1998). The TetO2 sequences serve as binding sites for 4 Tet repressor molecules (comprising two Tet repressor homodimers) and confer tetracycline-responsiveness to your gene of interest. The Tet repressor is expressed from the pcDNA6/TR plasmid. For more information about the TetO2 sequences, see the next page. For more information about the pcDNA6/TR plasmid and the Tet repressor, refer to the T-REx System manual.In the absence of tetracycline, expression of your gene of interest is repressed by the binding of Tet repressor homodimers to the TetO2 sequences. Addition of tetracycline to the cells derepresses the hybrid CMV/TetO2 promoter in pcDNA5/TO and allows expression of your gene of interestTet 操纵子序列The promoters of bacterial tet genes contain two types of operator sequences, O1 and O2, that serve as high affinity binding sites for the Tet repressor (Hillen and Berens, 1994; Hillen et al., 1983). Each O1 and O2 site binds to one Tet repressor homodimer. While Tet repressor homodimers bind to both tet operators with high affinity, studies have shown that the affinity of the Tet repressor homodimer for O2 is three- to five-fold higher than it is for O1 (Hillen and Berens, 1994).Tet operators have been incorporated into heterologous eukaryotic promoters to allow tetracycline-regulated gene expression in mammalian cells (Gossen and Bujard, 1992; Yao et al., 1998). In the T-REx System, two copies of the O2 operator sequence (TetO2) were inserted into the strong CMV promoter of pcDNA5/TO to allow regulated expression of your gene of interest by tetracycline. We use the TetO2 operator sequence in pcDNA5/TO to maximize repression of basal gene expression. For more detailed information about tet operators, refer to Hillen and Berens (1994).Yao et al. (1998) have recently demonstrated that the location of tet operator sequences in relation to the TATA box of a heterologous promoter is critical to the function of the tet operator. Regulation by tetracycline is only conferred upon a heterologous promoter by proper spacing of the TetO2 sequences from the TATA box (Yao et al., 1998). For this reason, the first nucleotide of the TetO2 operator sequence has been placed 10 nucleotides after the last nucleotide of the TATA element in the CMV promoter in pcDNA5/TO.In other tetracycline-regulated systems, the TetO2 sequences are located upstream of the TATA element in the promoter of the inducible expression vector (Gossen and Bujard, 1992). These systems differ substantially from the T-REx System in that they use regulatory molecules composed of the Tet repressor fused to a viral transactivation domain. The presence of viral transactivation domains appears to overcome the requirement for specific positioning of the TetO2 sequences in relation to the TATA box of the heterologous promoter. However, the presence of viral transactivation domains has been found to have deleterious effects in some mammalian cell lines.T-REx 细胞系For your convenience, Life Technologies has available several mammalian cell lines that stably express the Tet repressor. T-REx-293 cells, T-REx-HeLa cells, T-REx CHO cells, and T-REx-Jurkat cells express the Tet repressor from pcDNA6/TR and should be maintained in medium containing blasticidin. Expression of your gene ofinterest from pcDNA5/TO may be assayed by transfection of your pcDNA5/TO construct into any of the T-REx cell lines and induction with tetracycline.pcDNA5/TO载体序列pcDNA5/TO 5667 bpGACGGATCGGGAGATCTCCCGATCCCCTATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTT AAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCGCGAGCAAAATTTAAGCTACA ACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTGCTTAGGGTTAGGCGTTTTGCGCTGCTTCGCG ATGTACGGGCCAGATATACGCGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTC ATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCG CCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCC ATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCC AAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTA TGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGC AGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAA TGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACG CAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCCCTATCAGTGATAGAGATC TCCCTATCAGTGATAGAGATCGTCGACGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCATCC ACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGACTCTAGCGTTTAAACTTAAG CTTGGTACCGAGCTCGGATCCACTAGTCCAGTGTGGTGGAATTCTGCAGATATCCAGCACAGTGGCGGCC GCTCGAGTCTAGAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCT GTTGTTTGCCCCTCCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAA ATGAGGAAATTGCATCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAG CAAGGGGGAGGATTGGGAAGACAATAGCAGGCATGCTGGGGATGCGGTGGGCTCTATGGCTTCTGAGGCG GAAAGAACCAGCTGGGGCTCTAGGGGGTATCCCCACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTG TGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCC TTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGA TTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGC CCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAAC TGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTAT TGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTAATTCTGTGGAATGTGTGTCAGTTAGG GTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACC AGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAA CCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCA TGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGCTATTCCAGAAGTAG TGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGCTCCCGGGAGCTTGTATATCCATTTTCGGAT CTGATCAGCACGTGATGAAAAAGCCTGAACTCACCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAGTT CGACAGCGTCTCCGACCTGATGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTTCAGCTTCGATGTAGGA GGGCGTGGATATGTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTACAAAGATCGTTATGTTTATCGGC ACTTTGCATCGGCCGCGCTCCCGATTCCGGAAGTGCTTGACATTGGGGAATTCAGCGAGAGCCTGACCTA TTGCATCTCCCGCCGTGCACAGGGTGTCACGTTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTG CAGCCGGTCGCGGAGGCCATGGATGCGATCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTCGGCCCAT TCGGACCGCAAGGAATCGGTCAATACACTACATGGCGTGATTTCATATGCGCGATTGCTGATCCCCATGTGTATCACTGGCAAACTGTGATGGACGACACCGTCAGTGCGTCCGTCGCGCAGGCTCTCGATGAGCTGATG CTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTCGGCTCCAACAATGTCCTGA CGGACAATGGCCGCATAACAGCGGTCATTGACTGGAGCGAGGCGATGTTCGGGGATTCCCAATACGAGGT CGCCAACATCTTCTTCTGGAGGCCGTGGTTGGCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGG CATCCGGAGCTTGCAGGATCGCCGCGGCTCCGGGCGTATATGCTCCGCATTGGTCTTGACCAACTCTATC AGAGCTTGGTTGACGGCAATTTCGATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATC CGGAGCCGGGACTGTCGGGCGTACACAAATCGCCCGCAGAAGCGCGGCCGTCTGGACCGATGGCTGTGTA GAAGTACTCGCCGATAGTGGAAACCGACGCCCCAGCACTCGTCCGAGGGCAAAGGAATAGCACGTGCTAC GAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTG GATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCCAACTTGTTTATTGCAGCTTAT AATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTT GTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGTATACCGTCGACCTCTAGCTAGAGCTTGGC GTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCC GGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCAC TGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGG CGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGG CGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGA ACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAG GCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTA TAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCG GATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAG TTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCC TTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTG GTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGG CTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGT AGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTTGGTTTTTTGTTTGCAAGCAGCAGATTACGC GCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAA CTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAA TGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAAC TACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCG CCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAA CGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGT TCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTC CGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCT TACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAG TGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTT TAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGG TGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCA TACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGA ATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTC其他哺乳动物表达载体:pCHO1.0 pBApo-CMV-Pur pOPRSVIpcDNA3.1/His C pcDNA5/FRT/V5-His-TOPO pREP4pcDNA3.1/His B pcDNA5/FRT/TO-TOPO pDual-GCpcDNA3.1/His A pcDNA5/TO pBK-RSVpIRESpuro3 pcDNA5/FRT/TO pBK-CMVpIRES2-EGFP pcDNA5/FRT pBI-CMV4pTT5 pFLAG-CMV2 pcDNA4/TO/Myc-His/LacZ pNFkB-DD-tdTomato pcDNA3.1/CT-GFP-TOPO pOPI3CATpBI-CMV5 pcDNA3.1/NT-GFP-TOPO pGene/V5-His B pSEAP2-Basic pOptiVEC-TOPO pSwitchpSEAP2-Control pCMV-MEKK1 pCMVLacIpBI-CMV3 pCMV-MEK1 pVgRxRpBI-CMV2 pCMV-PKA pINDpBI-CMV1 pcDNA6.2/nTC-Tag-DEST pTRE3G-LucpNFκB-MetLuc2-Reporter pcDNA6.2/cTC-Tag-DEST pTRE3GpCRE-MetLuc2-Reporter pcDNA3.2/V5/GW/D-TOPO pTRE2-hygropAcGFP1-Actin pcDNA6.2/V5/GW/D-TOPO pTRE-TightpAcGFP1-N In-Fusion Ready pcDNA6.2/nGeneBLAzer-GW/D-TOPO pTK-hygpAcGFP1-C3 pcDNA6.2/C-YFP-DEST pTet-OnpAcGFP1-C pcDNA6.2/cGeneBLAzer-DEST pTet-OffpAcGFP1-p53 pcDNA6/V5-His A pTet on advanced pAcGFP1-Mito pcDNA6/V5-His B pRevTREpAcGFP1-Mem pcDNA6/V5-His C pRevTet-OnpAcGFP1-Lam pcDNA6/myc-His C pRevTet-OffpAcGFP1-Golgi pcDNA6/myc-His A pCMV-Tet3GpAcGFP1-F pcDNA6/myc-His B pTRE2pAcGFP1-Hyg-C1 pcDNA6.2/nGeneBLAzer-DEST pBD-NF-κBpAsRed2-N1 pcDNA4/HisMax-TOPO pCMV-ADptdTomato-N1 pcDNA6.2/nLumio-DEST pCMV-BDpCMV-tdTomato pcDNA6.2/cLumio-DEST pBIND-Id ControlpCRE-DD-tdTomato pcDNA4/myc-His C pBINDpCMV-DsRed-Express2 pcDNA4/HisMax C pG5 luciferasepEF1α-tdTomato pcDNA4/HisMax A pACT-MyoDpCRE-hrGFP c-Flag pcDNA3 pACTptdTomato-C1 pcDNA4/HisMax B pCMV-SPORT6 pAsRed2-C1 pcDNA4/myc-His B pGL4.13pGL3-Promoter pcDNA4/myc-His A pGL4.19pGL3 basic pcDNA4/His C pGL4.26pAcGFP1-C2 pcDNA4/His B pGL4.20pAcGFP1-C1 pcDNA4/His A pGL4.29pAcGFP1-N3 pcDNA6/TR pGL4.30pAcGFP1-N2 pcDNA4/TO/Myc-His A pGL4.27pAcGFP1-N1 pcDNA4/TO pGL4.75pAcGFP1-C In-Fusion Ready pcDNA4/TO/Myc-His B pGL4.10pCRE-DD-AmCyan1 pcDNA4/TO/Myc-His C pGRN145pNFkB-DD-AmCyan1 pcDNA3.3-TOPO pSecTag2 A pDsRed2-Bid pBudCE4.1 pEBVHis B pDsRED2-Mito pFLAG-CMV-4 pEBVHis ApDD-AmCyan1 Reporter pFLAG-CMV-3 pCMV-Tag 3C pAmCyan1-N1 pFLAG-CMV-2 pCMV-Tag 3A pAmCyan1-C1 pFLAG-CMV-5a pCMV-Tag 3BpEF1α-IRES-DsRed-Express2 p3XFLAG-CMV-9 pCMV-Tag 5CpEF1α-DsRed-Monomer-N1 p3xFLAG-CMV-10 pCMV-Tag 5A pDsRED-Monomer-N1 p3XFLAG-CMV-8 pCMV-Tag 4A pDsRed-Express-N1 p3XFLAG-CMV-7.1 pCMV-Tag 5Bp3XFLAG-CMV-7 pDsRed-Monomer-N In-Fusion Ready pCMV-Tag 4B pDsRed-Express-C1 p3XFLAG-CMV-13 pCMV-Tag 2C pIRES2-ZsGreen1 p3XFLAG-CMV-14 pCMV-Tag 2B pDsRed-Express2-C1 plRES2-ZsGreen1 pCMV-Tag 2A pDsRed-Express2-N1 pBApo-EF1α-pur pCMV-LacZpEF1α-DsRed-Express2 pBApo-EF1α-neo pCMV-MycpIRES2-DsRed-Express pBApo-CMV pEF1α-IRES-AcGFP1 pIRES2-DsRed-Express2 pBApo-CMV-neo pEF1α-IRES-ZsGreen1 pIRES-hrGFP-1a pIRES-EGFP pEF1α-AcGFP1-N1 pIRESneo2 pIRESneo3 pIRES2-DsRed2 pIRESneo pDsRed-Monomer pIRES2-AcGFP1 pIREShyg3 pIRES。